IMFINZI® Patient Program –Private Patients
Eligible Stage III non-small cell lung cancer patients using private service can enrol in the below patient programs in Hong Kong Pharmaceutical Care Foundation
HK-8226 12/5/2022
Eligible Stage III non-small cell lung cancer patients using private service can enrol in the below patient programs in Hong Kong Pharmaceutical Care Foundation
HK-8226 12/5/2022